554430-95-4

Upstream product

• 554430-78-3 3-(2,4-dimethoxy-phenyl)-7-methoxy-4-methyl-chromen-2-one 
• 749901-81-3 4-bromomethyl-3-[(2,4-dimethoxy)phenyl]-7-methoxycoumarin 
• 554429-98-0 7-acetoxy-3-(2,4-dimethoxyphenyl)-4-methylcoumarin 
• 89-84-9 2',4'-dihydroxy-4-acetophenone 
• 6496-89-5 2,4-dimethoxyphenylacetic acid 
• 554430-38-5 C₁₆H₁₁BrO₅ 
• 554430-69-2 2,8-dihydroxy-11H-chromeno[4,3-c]chromen-5-one 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 553681-47-3 2,8-bis(tert-butyl-dimethyl-silyloxy)-5,11-dihydro-chromeno[4,3-c]chromen-5-ol 
• 554430-87-4 2,8-bis(tert-butyl-dimethyl-silyloxy)-11H-chromeno[4,3-c]chromen-5-one 
• 554430-18-1 5-(tert-butyl-dimethyl-silyloxy)-2-[7-(tert-butyl-dimethyl-silyloxy)-4-(hydroxy-phenyl-methyl)-2H-chromen-3-yl]-phenol 

Relevant academic research and scientific papers

FUSED TETRACYCLIC HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

The present invention relates to novel Fused Tetracyclic Heterocyclic Compounds of Formula I: (I), wherein A, A', R2A, R2B, R7, R8, R9, and R10 are defined herein. The compounds and their p

FUSED TETRACYCLIC HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES

The present invention relates to novel Fused Tetracyclic Heterocyclic Compounds of Formula (I): wherein A, A', R2A, R2B, R7, R8, R9 and R10 are defined herein. The compounds and their pharm

Novel chromene-derived selective estrogen receptor modulators useful for alleviating hot flushes and vaginal dryness

A novel SERM (selective estrogen receptor modulators), 1-(R), a chromene-derived bisbenzopyran, was discovered to alleviate hot flushes and effectively increase vaginal fluidity in rats. Moreover, 1-(R) was found to have beneficial effects on plasma chole